International Clinical Trial: A prospective, single arm, open label, historical controlled trial of probiotics modulating the intestinal flora in children with autism spectrum disorder and the efficacy and safety of gastrointestinal symptoms

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119264) titled 'A prospective, single arm, open label, historical controlled trial of probiotics modulating the intestinal flora in children with autism spectrum disorder and the efficacy and safety of gastrointestinal symptoms' on Feb. 25.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Suzhou Municipal Hospital

Condition: Autism spectrum disorder

Recruitment Status: Not Recruiting

Phase: 1

Date of First Enrollment: 2026-03-01

Target Sample Size: Intervention group:66;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=310304

Published by ...